News & Updates

Tislelizumab improves survival in advanced gastric/gastro-oesophageal junction adenocarcinoma
Tislelizumab improves survival in advanced gastric/gastro-oesophageal junction adenocarcinoma
04 Jun 2024 byStephen Padilla

First-line treatment with tislelizumab plus chemotherapy for advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma yields better overall survival and an acceptable safety profile compared with chemotherapy plus placebo in patients with a programmed death-ligand 1 (PD-L1) tumour area positivity (TAP) score of ≥5 percent, a study has shown.

Tislelizumab improves survival in advanced gastric/gastro-oesophageal junction adenocarcinoma
04 Jun 2024
Legume intake reduces colorectal cancer risk
Legume intake reduces colorectal cancer risk
03 Jun 2024 byStephen Padilla

Eating legumes may help avert the development of colorectal cancer, according to a study that has found an inverse association between legume consumption and colorectal cancer risk.

Legume intake reduces colorectal cancer risk
03 Jun 2024